Marcella Manerba

Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase

Marcella Manerba, Marina Vettraino, L. Fiume et al. · ChemMedChem · 2011 · 190 citations · Full text

Molecular Pharmacology, Metabolic Pathways, Glycolysis Inhibitors +15

Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways

Fulvia Farabegoli, Marina Vettraino, Marcella Manerba et al. · European Journal of Pharmaceutical Sciences · 2012 · 149 citations

Breast Oncology, Endocrine-related Cancer, Medicine +9

Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells

Marcella Manerba, Lorenza Di Ianni, Marzia Govoni et al. · European Journal of Pharmaceutical Sciences · 2016 · 73 citations · Full text

Inflammation, Anti-inflammatory, Lactate Dehydrogenase Inhibitors +7

Impairment of Aerobic Glycolysis by Inhibitors of Lactic Dehydrogenase Hinders the Growth of Human Hepatocellular Carcinoma Cell Lines

L. Fiume, Marcella Manerba, Marina Vettraino et al. · Pharmacology · 2010 · 59 citations

Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1

Marina Vettraino, Marcella Manerba, Marzia Govoni et al. · Anti-Cancer Drugs · 2013 · 51 citations

Immunology, Pathology, Burkitt Lymphoma Cells +21